<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
In 1967 Zaoral and coworkers synthesized several analogues of vasopressin. One of these derivatives, 1-deamino-8-D-arginine vasopressin (DDAVP, desmopressin), soon became the treatment of choice for diabetes insipidus centralis. DDAVP has a prolonged half-life and a decreased pressor activity when compared with the parent hormone vasopressin (VP). This allows the use of significantly higher dosages without the cardiovascular side effects of VP. Gader et al. (1973), Cash (1974) and Mannucci (1977) observed that DDAVP increases Factor VIII (FVIII) and von Willebrand Factor (vVF) in healthy subjects and patients with bleeding disorders such as milder forms of haemophilia A and von Willebrand’s disease.In these disorders, desmopressin proved not only to be a substitute for blood products, but also the most effective treatment.
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |